Biology Reference
In-Depth Information
[134]
Malenka, R.C., Bear, M.F. (2004). LTP and LTD: an embarrassment of riches.
Neuron
,
44, 5-21.
[135]
Marcaggi, P., Attwell, D. (2005). Endocannabinoid signaling depends on the spatial
pattern of synapse activation.
Nat Neurosci
, 8, 776-781.
[136]
Marsicano, G., Wotjak, C.T., Azad, S.C., Bisogno, T., Rammes, G., Cascio, M.G.,
Hermann, H., Tang, J., Hofmann, C., Zieglgansberger, W., Di Marzo, V., Lutz, B.
(2002). The endogenous cannabinoid system controls extinction of aversive memories.
Nature
, 418, 530-534.
[137]
Marsicano, G., Wotjak, C.T., Azad, S.C., Bisogno, T., Rammes, G., Cascio, M.G.,
Hermann, H., Tang, J., Hofmann, C., Zieglgansberger, W., Di Marzo, V., Lutz, B.
(2002). The endogenous cannabinoid system controls extinction of aversive memories.
Nature
, 418, 530-534.
[138]
Mato, S., Chevaleyre, V., Robbe, D., Pazos, A., Castillo, P.E., Manzoni, O.J. (2004). A
single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic
plasticity.
Nat Neurosci
, 7, 585-586.
[139]
Matsuda, L.A., Bonner, T.I., Lolait, S.J. (1993). Localization of cannabinoid receptor
mRNA in rat brain.
J Comp Neurol
, 327, 535-550.
[140]
Mazzola, C., Micale, V., Drago, F. (2003). Amnesia induced by beta-amyloid
fragments is counteracted by cannabinoid CB1 receptor blockade.
Eur J Pharmacol
,
477, 219-225.
[141]
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz,
A.R., Gopher, A., Almog, S., Martin, B.R., Compton, D.R., Pertwee, R.G., Griffin,
G.Bayewitch, M., Barg, J., Vogel, Z. (1995). Identification of an endogenous 2-
monoglyceride, present in canine gut, that binds to cannabinoid receptors.
Biochem
Pharmacol
, 50, 83-90.
[142]
Mechoulam, R., Fride, E., Di Marzo, V. (1998). Endocannabinoids.
Eur J Pharmacol
,
359, 1-18.
[143]
Melis, M., Perra, S., Muntoni, A.L., Pillolla, G., Lutz, B., Marsicano, G., Di Marzo, V.,
Gessa, G.L., Pistis, M. (2004). Prefrontal cortex stimulation induces 2-arachidonoyl-
glycerol-mediated suppression of excitation in dopamine neurons.
J Neurosci
, 24,
10707-10715.
[144]
Melis, M., Pistis, M., Perra, S., Muntoni, A.L., Pillolla, G., Gessa, G.L. (2004).
Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in
Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 Receptors.
J. Neurosci
, 24, 53-62.
[145]
Miura, M., Watanabe, M., Offermanns, S., Simon, M.I., Kano, M. (2002). Group I
metabotropic glutamate receptor signaling via Galpha q/Galpha 11 secures the
induction of long-term potentiation in the hippocampal area CA1.
J Neurosci
, 22, 8379-
8390.
[146]
Morishita, W., Alger, B.E. (2000). Differential effects of the group II mGluR agonist,
DCG-IV, on depolarization-induced suppression of inhibition in hippocampal CA1 and
CA3 neurons.
Hippocampus
, 10, 261-268.
[147]
Morisset, V., Urban, L. (2001). Cannabinoid-induced presynaptic inhibition of
glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord.
J
Neurophysiol
, 86, 40-48.
